Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06509880

Immunosurveillance for Metastatic Colorectal Cancer (ISMCC)

The Role of Neutrophil Mitochondrial Dysfunction in Medical Rehabilitation During Palliative Chemotherapy for Metastatic Colorectal Cancer

Sponsor: MIPO Clinic

Conditions Monitoring, Immunologic

Interventions Adenorine FOLFOX regimen Placebo

Updated 2 times since 2024 Last updated: Jul 14, 2024 Started: Jul 15, 2024 Primary completion: Jul 25, 2024 Completion: Jul 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Monitoring, Immunologic and is currently ongoing. MIPO Clinic leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE1/PHASE2
Aug 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE1/PHASE2

First recorded

Jul 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MIPO Clinic

Data source: MIPO Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Almaty, Kazakhstan